No Prescription |
 |
 | ||
|
Claramax Clarinex |
|
| ||
No Prescription » Prescription Drugs 4 » Claramax Clarinex Desloratadine is used to relieve hay fever and allergy symptoms including sneezing; runny nose; and red itchy tearing eyes. It is also used to treat hives. Desloratadine is in a class of medications called antihistamines. It works by blocking histamine a substance in the body that causes allergic symptoms. Desloratadine may cause less drowsiness than other antihistamines.Desloratadine comes as a tablet and an orally disintegrating tablet to take by mouth. It is usually taken once a day with or without food. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take desloratadine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.To take the orally disintegrating tablet use dry hands to peel back the foil packaging. Immediately take out the tablet and place it on your tongue. The tablet will quickly dissolve and can be swallowed with saliva. Orally disintegrating tablets may be taken with or without water. Buy Claramax Clarinex and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Claramax Clarinex: Product Type: Prescription Drugs 4 Claramax ( Clarinex Generic Desloratadine ) Claramax (Clarinex Generic Desloratadine) Clarinex Generic Desloratadine 5mg 7 Tablets 14(2 x 7) Tablets 28(4 x 7) Tablets Clarinex Generic Desloratadine Claramax
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
